Detalhe da pesquisa
1.
Using family history forms in pediatric oncology to identify patients for genetic assessment.
Curr Oncol
; 24(6): e441-e445, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29270053
2.
Living with the BRCA1 and BRCA2 genetic mutation: learning how to adapt to a virtual chronic illness.
Psychol Health Med
; 19(1): 103-14, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23607692
3.
Living with the BRCA genetic mutation: an uncertain conclusion to an unending process.
Psychol Health Med
; 18(2): 125-34, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22670560
4.
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.
Br J Cancer
; 106(8): 1460-3, 2012 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415235
5.
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
J Clin Oncol
; 12(7): 1458-67, 1994 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-7912725
6.
Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer.
J Clin Oncol
; 17(10): 3038-47, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10506598
7.
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study.
J Clin Oncol
; 21(5): 843-50, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12610183
8.
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.
J Clin Oncol
; 17(5): 1413-24, 1999 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-10334526
9.
Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trials.
Eur J Cancer
; 28(2-3): 667-72, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-1591090
10.
Estimates of the lifetime costs of breast cancer treatment in Canada.
Eur J Cancer
; 36(6): 724-35, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10762744
11.
Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study.
Eur J Cancer
; 32A(11): 1876-87, 1996 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8943669
12.
Concurrent use of multiple low dose chemotherapy agents with differing mechanisms of action as a strategy vs passive resistance: A pilot study.
Int J Oncol
; 15(4): 693-9, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10493950
13.
Concurrent use of multiple chemotherapy resistance modulators with etoposide in patients with resistant malignancies.
Int J Oncol
; 11(4): 709-16, 1997 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21528265
14.
Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer.
Lung Cancer
; 23(1): 19-30, 1999 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-10100143
15.
Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer.
Lung Cancer
; 15(1): 115-23, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8865129
16.
Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer.
Lung Cancer
; 18(1): 83-94, 1997 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9268950
17.
Pilot study of multiple chemotherapy resistance modulators plus epirubicin in the treatment of resistant malignancies.
Cancer Chemother Pharmacol
; 41(1): 1-8, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9443607
18.
Clinical characteristics and the impact of surgery and chemotherapy on survival of patients with advanced and metastatic bronchioloalveolar carcinoma: a retrospective study.
Clin Lung Cancer
; 1(3): 211-5; discussion 216, 2000 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14733647
19.
Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
Am J Clin Oncol
; 18(2): 149-55, 1995 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-7534977
20.
A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma.
Am J Clin Oncol
; 23(3): 292-6, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10857897